An evaluation of B-type Natriuretic Peptide in Addition to Myoglobin, Creatine Kinase-MB, and Troponin I on the Emergency Department Patients with Acute Myocardial Infarction
Keywords:
B-type natriuretic peptide, myocardial infarction, diagnosisAbstract
Objective: To assess the accuracy of B-type natriuretic peptide (BNP) in addition to myoglobin, creatine kinase-MB (CKMB),
and troponin I to diagnose patients with non ST-segment elevation myocardial infarction (NSTEMI) at the emergency
department.
Methods: During January to July 2007, a total of 100 patients with suspected acute myocardial infarction at the emergency
department were included. 50 were classified as NSTEMI and 50 as non-NSTEMI according to the final hospital diagnosis.
Blood samples for investigation of myoglobin, CK-MB, troponin I, and BNP analysis were collected in EDTA tubes
concomitantly with routine blood specimens from the emergency department and measured by Biosite Triage Cardioprofiler
Panel (Biosite Inc., San Diego, CA)
Results: The diagnostic sensitivity of Myoglobin and BNP (cut-off value of 100 pg/mL) for acute myocardial infarction
(AMI) was significantly higher than CK-MB and troponin-I at the emergency department (76 and 82 vs. 36 and 24%,
respectively, P< 0.001). BNP in addition to myoglobin, CK-MB, and troponin I improved the diagnostic sensitivity from
86% to 100%. The optimum cut-off point levels for myoglobin, CK-MB, troponin-I, and BNP were 150 ng/mL, 3.8 ng/mL,
0.15 ng/mL and 147 pg/mL respectively. Using the optimal cut-off point, the sensitivity was 96% and specificity was 46%
in diagnosis for myocardial infarction.
Conclusion: Multiple cardiac markers by use of quantitative point-of-care testing for myoglobin, CK-MB, troponin-I and
BNP are useful for ruling out patients presenting to the emergency department with suspected NSTEMI.
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following conditions:
Copyright Transfer
In submitting a manuscript, the authors acknowledge that the work will become the copyrighted property of Siriraj Medical Journal upon publication.
License
Articles are licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0). This license allows for the sharing of the work for non-commercial purposes with proper attribution to the authors and the journal. However, it does not permit modifications or the creation of derivative works.
Sharing and Access
Authors are encouraged to share their article on their personal or institutional websites and through other non-commercial platforms. Doing so can increase readership and citations.